/

Empresas

Ni

No verificado

Niagen Bioscience, Inc

Sobre qué escribimos

BiotecnologíaCienciaFarmacéuticaIndustriaSalud

39 Comunicados de prensa

Ver todos los comunicados de prensa

28/04/2026

Mercado laboral

Industria

Salud

Ciencia

Sanidad

Farmacéutica

Biotecnología

Niagen Bioscience Adds Olympia Pharmaceuticals to 503B Compounding Partner Network for Niagen Plus™

Fuente

Niagen Bioscience, Inc

Editor

1.00

0

22/04/2026

Web y redes sociales

Telefonía

Finanzas

Mercado de valores

Salud

Comunicación

Ciencia

Sanidad

Niagen Bioscience to Report First Quarter 2026 Financial Results on Wednesday, May 6, 2026

Fuente

Niagen Bioscience, Inc

Editor

1.00

0

09/04/2026

Mercado laboral

Industria

Salud

Fitness

Ciencia

Farmacéutica

Biotecnología

Niagen Bioscience Collaborates with USP to Establish First-Ever USP Monograph for Nicotinamide Riboside Chloride (NRCl), the Patented Form in Niagen®

Fuente

Niagen Bioscience, Inc

Editor

1.00

0

31/03/2026

Niagen Bioscience Announces First Cruise Ship Clinic Partnership with OneSpaWorld, Bringing the NAD-Boosting Benefits of Niagen IV to the High Seas

Fuente

Niagen Bioscience, Inc

Editor

1.00

0

19/03/2026

Finanzas

Biotecnología

Salud

Ciencia

Farmacéutica

Niagen Bioscience Increases Share Repurchase Program to $20 Million

Fuente

Niagen Bioscience, Inc

Editor

1.00

0

18/03/2026

Eventos

Web y redes sociales

Biotecnología

Salud

Ciencia

Farmacéutica

Niagen Bioscience to Present at the 38th Annual ROTH Conference

Fuente

Niagen Bioscience, Inc

Editor

1.00

0

17/03/2026

Salud

Sanidad

Fitness

Ciencia

Biotecnología

Industria

Niagen Bioscience Surpasses 300 External Research Agreements from Leading Global Institutions on Niagen®, Contributing to 45 Published Clinical Studies

Fuente

Niagen Bioscience, Inc

Editor

1.00

0

10/03/2026

Niagen Bioscience Launches Niagen® Skincare Innovation Lab and Debuts Dermatologist-Tested Niagen NanoCloud™, From Tru Niagen Powered by Patented Niagen®

Fuente

Niagen Bioscience, Inc

Editor

1.00

0

04/03/2026

Web y redes sociales

Telefonía

Mercado de valores

Biotecnología

Farmacéutica

Salud

Medicina - Varios

Niagen Bioscience Reports 30% Year-Over-Year Net Sales Increase to $129.4 million, 103% Net Income Increase to $17.4 million or $0.22 Basic EPS in 2025

Fuente

Niagen Bioscience, Inc

Editor

1.00

0

26/02/2026

Administración de Empresas

Salud

Fitness

Sanidad

Farmacéutica

Biotecnología

Niagen Bioscience to Streamline and Focus its Operations with the Sale of ChromaDex Reference Standards Business to LGC in All-Cash Transaction

Fuente

Niagen Bioscience, Inc

Editor

1.00

0

Seguidores

0

Compatibilidad

0